This inventor holds 1 USPTO granted patent. Top assignee: The University of Hong Kong. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations by Fung Yu Huang in Non-Alcoholic Fatty Liver Disease Diagnosis
Introduction
Fung Yu Huang is an accomplished inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in the area of non-alcoholic fatty liver disease (NAFLD). His innovative work focuses on the development of microbial biomarkers that enable accurate and non-invasive diagnosis of this condition.
Latest Patents
Fung Yu Huang holds 1 patent related to his research. The patent, titled "Fecal microbial biomarkers for non-alcoholic fatty liver disease," discloses microbial biomarkers and methods for diagnosing NAFLD in subjects. The microbial biomarkers include various strains and subspecies, and the methods involve measuring the abundance or copy number of these biomarkers in samples such as bodily fluids, mucus, or stool. Additionally, the patent describes methods for treating subjects with NAFLD by administering a composition containing these biomarkers.
Career Highlights
Fung Yu Huang is affiliated with The University of Hong Kong, where he conducts his research and develops innovative solutions for medical diagnostics. His work has the potential to significantly improve the accuracy of NAFLD diagnosis, which is crucial for effective treatment and management of the disease.
Collaborations
Fung Yu Huang collaborates with notable colleagues, including Hein Min Tun and Sai Sai Zhang, who contribute to his research efforts and enhance the impact of his work in the field.
Conclusion
Fung Yu Huang's contributions to the diagnosis of non-alcoholic fatty liver disease through innovative microbial biomarkers represent a significant advancement in medical science. His work not only aids in accurate diagnosis but also opens avenues for effective treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
